SAN DIEGO – March 14, 2013 — OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Punit Dhillon, President and CEO, will present at the 25th Annual Roth Conference at the Ritz-Carlton, Laguna Niguel in Dana Point, California, on Tuesday, March 19th at 8:00AM Pacific Time.
Mr. Dhillon will provide an overview of the Company and its milestones during the presentation, and will be conducting one-on-one meetings with investors who are registered to attend the conference.
The presentation will be webcast live. To access the webcast, please visit http://wsw.com/webcast/roth27/oncs/. The webcast will be archived for 90 days.
About the Annual Roth Conference
The 25th Annual Roth Conference is designed to provide investors with a unique opportunity to gain insight into emerging growth companies across a variety of sectors, including Business Services, Consumer, Cleantech, Industrials & Resources, Healthcare, Metals & Mining and Technology & Media.
The event is one of the largest of its kind in the U.S. It will feature presentations from hundreds of growth companies, expert panels and thousands of management one-on-one/small group meetings. To find out more, visit www.roth.com.